These results may provide in vitro rational for “adding on” a PDE4 inhibitor to the treatment regimen of patients with severe COPD taking inhaled corticosteroids who still suffer frequent exacerbations. The gene discussed is PDE4A; the disease is chronic obstructive pulmonary disease.